Corrected Proof scheduled for 17 (12)

Noninvasive Models to Predict Liver Fibrosis in Patients with Chronic Hepatitis B: A Study from Turkey

Authors Information
Article Notes and Dates
To Cite : Korkmaz P, Demirturk N, Batırel A, Cem Yardimci A, Cagir U, et al. Noninvasive Models to Predict Liver Fibrosis in Patients with Chronic Hepatitis B: A Study from Turkey, Hepat Mon. Online ahead of Print ;In Press(In Press):e60266. doi: 10.5812/hepatmon.60266.
Copyright: Copyright © 0, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited..
Abstract
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. European Association For The Study Of The L. EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. J Hepatol. 2012;57(1):167-85. doi: 10.1016/j.jhep.2012.02.010. [PubMed: 22436845].
  • 2. Zeng MD, Lu LG, Mao YM, Qiu DK, Li JQ, Wan MB, etal. Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model. Hepatology. 2005;42(6):1437-45. doi: 10.1002/hep.20960. [PubMed: 16317674].
  • 3. Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology. 2000;32(3):477-81. doi: 10.1053/jhep.2000.16602. [PubMed: 10960438].
  • 4. Siddique I, El-Naga HA, Madda JP, Memon A, Hasan F. Sampling variability on percutaneous liver biopsy in patients with chronic hepatitis C virus infection. Scand J Gastroenterol. 2003;38(4):427-32. [PubMed: 12739716].
  • 5. Regev A, Berho M, Jeffers LJ, Milikowski C, Molina EG, Pyrsopoulos NT, etal. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol. 2002;97(10):2614-8. doi: 10.1111/j.1572-0241.2002.06038.x. [PubMed: 12385448].
  • 6. Standish RA, Cholongitas E, Dhillon A, Burroughs AK, Dhillon AP. An appraisal of the histopathological assessment of liver fibrosis. Gut. 2006;55(4):569-78. doi: 10.1136/gut.2005.084475. [PubMed: 16531536].
  • 7. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, etal. Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22(6):696-9. [PubMed: 7560864].
  • 8. Lok AS, Ghany MG, Goodman ZD, Wright EC, Everson GT, Sterling RK, etal. Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort. Hepatology. 2005;42(2):282-92. doi: 10.1002/hep.20772. [PubMed: 15986415].
  • 9. Pinzani M, Rombouts K, Colagrande S. Fibrosis in chronic liver diseases: diagnosis and management. J Hepatol. 2005;42 Suppl(1):S22-36. doi: 10.1016/j.jhep.2004.12.008. [PubMed: 15777570].
  • 10. Hsieh YY, Tung SY, Lee K, Wu CS, Wei KL, Shen CH, etal. Routine blood tests to predict liver fibrosis in chronic hepatitis C. World J Gastroenterol. 2012;18(8):746-53. doi: 10.3748/wjg.v18.i8.746. [PubMed: 22371634].
  • 11. Bonacini M, Hadi G, Govindarajan S, Lindsay KL. Utility of a discriminant score for diagnosing advanced fibrosis or cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol. 1997;92(8):1302-4. [PubMed: 9260794].
  • 12. Poynard T, Bedossa P. Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. METAVIR and CLINIVIR Cooperative Study Groups. J Viral Hepat. 1997;4(3):199-208. [PubMed: 9181529].
  • 13. Giannini E, Botta F, Fasoli A, Ceppa P, Risso D, Lantieri PB, etal. Progressive liver functional impairment is associated with an increase in AST/ALT ratio. Dig Dis Sci. 1999;44(6):1249-53. [PubMed: 10389705].
  • 14. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, etal. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38(2):518-26. doi: 10.1053/jhep.2003.50346. [PubMed: 12883497].
  • 15. Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, etal. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology. 2006;43(6):1317-25. doi: 10.1002/hep.21178. [PubMed: 16729309].
  • 16. Chen B, Ye B, Zhang J, Ying L, Chen Y. RDW to platelet ratio: a novel noninvasive index for predicting hepatic fibrosis and cirrhosis in chronic hepatitis B. PLoS One. 2013;8(7). e68780. doi: 10.1371/journal.pone.0068780. [PubMed: 23874760].
  • 17. Lee IC, Chan CC, Huang YH, Huo TI, Chu CJ, Lai CR, etal. Comparative analysis of noninvasive models to predict early liver fibrosis in hepatitis B e Antigen-negative Chronic Hepatitis B. J Clin Gastroenterol. 2011;45(3):278-85. doi: 10.1097/MCG.0b013e3181dd5357. [PubMed: 20505530].
  • 18. Kekilli M, Tanoglu A, Sakin YS, Kurt M, Ocal S, Bagci S. Is the neutrophil to lymphocyte ratio associated with liver fibrosis in patients with chronic hepatitis B?. World J Gastroenterol. 2015;21(18):5575-81. doi: 10.3748/wjg.v21.i18.5575. [PubMed: 25987782].
  • 19. Wai CT, Cheng CL, Wee A, Dan YY, Chan E, Chua W, etal. Non-invasive models for predicting histology in patients with chronic hepatitis B. Liver Int. 2006;26(6):666-72. doi: 10.1111/j.1478-3231.2006.01287.x. [PubMed: 16842322].
  • 20. Guzelbulut F, Sezikli M, Akkan-Cetinkaya Z, Yasar B, Ozkara S, Kurdas-Ovunc AO. AST-platelet ratio index in the prediction of significant fibrosis and cirrhosis in patients with chronic hepatitis B. Turk J Gastroenterol. 2012;23(4):353-8. [PubMed: 22965506].
  • 21. Erdogan S, Dogan HO, Sezer S, Uysal S, Ozhamam E, Kayacetin S, etal. The diagnostic value of non-invasive tests for the evaluation of liver fibrosis in chronic hepatitis B patients. Scand J Clin Lab Invest. 2013;73(4):300-8. doi: 10.3109/00365513.2013.773592. [PubMed: 23514016].
  • 22. Celikbilek M, Dogan S, Gursoy S, Zararsiz G, Yurci A, Ozbakir O, etal. Noninvasive assessment of liver damage in chronic hepatitis B. World J Hepatol. 2013;5(8):439-45. doi: 10.4254/wjh.v5.i8.439. [PubMed: 24023983].
  • 23. Teshale E, Lu M, Rupp LB, Holmberg SD, Moorman AC, Spradling P, etal. APRI and FIB-4 are good predictors of the stage of liver fibrosis in chronic hepatitis B: the Chronic Hepatitis Cohort Study (CHeCS). J Viral Hepat. 2014;21(12):917-20. doi: 10.1111/jvh.12279. [PubMed: 25131445].
  • 24. Eminler AT, Ayyildiz T, Irak K, Kiyici M, Gurel S, Dolar E, etal. AST/ALT ratio is not useful in predicting the degree of fibrosis in chronic viral hepatitis patients. Eur J Gastroenterol Hepatol. 2015;27(12):1361-6. doi: 10.1097/MEG.0000000000000468. [PubMed: 26352130].
  • 25. Xiao G, Yang J, Yan L. Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis-4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: a systemic review and meta-analysis. Hepatology. 2015;61(1):292-302. doi: 10.1002/hep.27382. [PubMed: 25132233].
  • 26. Halazun KJ, Hardy MA, Rana AA, Woodland D, Luyten EJ, Mahadev S, etal. Negative impact of neutrophil-lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma. Ann Surg. 2009;250(1):141-51. doi: 10.1097/SLA.0b013e3181a77e59. [PubMed: 19561458].
  • 27. Alkhouri N, Morris-Stiff G, Campbell C, Lopez R, Tamimi TA, Yerian L, etal. Neutrophil to lymphocyte ratio: a new marker for predicting steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease. Liver Int. 2012;32(2):297-302. doi: 10.1111/j.1478-3231.2011.02639.x. [PubMed: 22097893].
  • 28. Yesil A, Cosgun S, Erdem E, Kochan K, Gunduz F, Gonen C. The relationship between fibrosis level and blood neutrophil to lymphocyte ratio in chronic HBV patients. Age. 2013;38(13):37-14.
  • 29. Lou Y, Wang M, Mao W. Clinical usefulness of measuring red blood cell distribution width in patients with hepatitis B. PLoS One. 2012;7(5). e37644. doi: 10.1371/journal.pone.0037644. [PubMed: 22649548].
  • 30. Taefi A, Huang CC, Kolli K, Ebrahimi S, Patel M. Red cell distribution width to platelet ratio, a useful indicator of liver fibrosis in chronic hepatitis patients. Hepatol Int. 2015;9(3):454-60. doi: 10.1007/s12072-015-9638-9. [PubMed: 26088296].
  • 31. Ma J, Jiang Y, Gong G. Evaluation of seven noninvasive models in staging liver fibrosis in patients with chronic hepatitis B virus infection. Eur J Gastroenterol Hepatol. 2013;25(4):428-34. doi: 10.1097/MEG.0b013e32835cb5dd. [PubMed: 23358121].
  • 32. Zeng X, Xu C, He D, Li M, Zhang H, Wu Q, etal. Performance of several simple, noninvasive models for assessing significant liver fibrosis in patients with chronic hepatitis B. Croat Med J. 2015;56(3):272-9. [PubMed: 26088852].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiaion Alert via Google Reader

Cited By: